Fulgent Genetics Inc (FLGT)
NASDAQ:FLGT
Holding FLGT?
Track your performance easily

Fulgent Genetics (FLGT) Financial Statements

1,621 Followers

Fulgent Genetics Financial Overview

Fulgent Genetics's market cap is currently ―. The company's EPS TTM is $-5.527; its P/E ratio is -3.63; Fulgent Genetics is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is $-0.12. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 71.74M$ 71.03M$ 64.48M$ 70.50M$ 84.69M
Gross Profit$ 26.77M$ 26.49M$ 22.10M$ 25.23M$ 39.84M
EBIT$ -18.48M$ -11.21M$ -14.17M$ -30.89M$ 214.00K
EBITDA$ -9.28M$ -5.06M$ -7.51M$ -24.35M$ 6.63M
Net Income Common Stockholders$ -14.65M$ -8.74M$ -13.46M$ -128.15M$ -13.11M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 58.04M$ 65.11M$ 54.68M$ 97.47M$ 84.08M
Total Assets$ 1.23B$ 1.23B$ 1.23B$ 1.24B$ 1.36B
Total Debt$ 412.00K$ 412.00K$ 413.00K$ 1.18M$ 2.89M
Net Debt$ -57.63M$ -64.70M$ -54.26M$ -96.29M$ -81.19M
Total Liabilities$ 98.86M$ 117.50M$ 103.24M$ 102.04M$ 96.56M
Stockholders Equity$ 1.14B$ 1.13B$ 1.13B$ 1.14B$ 1.26B
Cash Flow-
Free Cash Flow$ -35.01M$ -8.64M$ 3.47M$ 11.83M$ 5.32M
Operating Cash Flow$ -15.51M$ 4.29M$ 7.27M$ 14.93M$ 10.24M
Investing Cash Flow$ 8.98M$ 7.30M$ -47.19M$ 24.27M$ 20.08M
Financing Cash Flow$ -567.00K$ -1.15M$ -2.81M$ -25.95M$ -4.47M
Currency in USD

Fulgent Genetics Earnings and Revenue History

Fulgent Genetics Debt to Assets

Fulgent Genetics Cash Flow

Fulgent Genetics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis